Search research articles
Contact Us
Filters
Showing results (31-40 of 187) with videos related to
Page
of 19
Sort By:
JACC. Case Reports
|
March 30, 2026
Atrial Fibrillation in Athletes: Mechanisms, Management, and Future Directions
Ibrahim Alameh, Ghina Al Fout, Michael D Ezekowitz, et al.
American Journal of Hypertension
|
December 21, 2005
Warfarin therapy and systolic hypertension in men with atrial fibrillation
Subramanian Krishnan, Namrata Chawla, Michael D Ezekowitz, et al.
Current Treatment Options in Cardiovascular Medicine
|
September 26, 2008
New developments in anticoagulation for atrial fibrillation
M Haris U Usman, Lawrence A Notaro, Harsh Patel, et al.
The American Journal of Cardiology
|
November 27, 2002
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
Sabu J George, Abhay J Dhond, Skip M Alderson, et al.
International Journal of Cardiology
|
October 9, 2015
Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures
Philip L Mar, Dmitry Familtsev, Michael D Ezekowitz, et al.
Circulation
|
September 27, 2006
Images in cardiovascular medicine. The case of a disappearing left atrial appendage thrombus: direct visualization of left atrial thrombus migration, captured by echocardiography, in a patient with atrial fibrillation, resulting in a stroke
Amit Parekh, Radhika Jaladi, Sushant Sharma, et al.
The New England Journal of Medicine
|
November 5, 2010
Newly identified events in the RE-LY trial
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 16, 2002
Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering
Roberta Baetta, Marina Camera, Carmen Comparato, et al.
American Heart Journal
|
November 14, 2017
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
Gregory Y H Lip, Naab Al-Saady, Michael D Ezekowitz, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 8, 2015
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score
Masatsugu Hori, Taku Fukaya, Eva Kleine, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 187) with videos related to
Sort By:
Page
of 19
JACC. Case Reports
|
March 30, 2026
Atrial Fibrillation in Athletes: Mechanisms, Management, and Future Directions
Ibrahim Alameh, Ghina Al Fout, Michael D Ezekowitz, et al.
American Journal of Hypertension
|
December 21, 2005
Warfarin therapy and systolic hypertension in men with atrial fibrillation
Subramanian Krishnan, Namrata Chawla, Michael D Ezekowitz, et al.
Current Treatment Options in Cardiovascular Medicine
|
September 26, 2008
New developments in anticoagulation for atrial fibrillation
M Haris U Usman, Lawrence A Notaro, Harsh Patel, et al.
The American Journal of Cardiology
|
November 27, 2002
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
Sabu J George, Abhay J Dhond, Skip M Alderson, et al.
International Journal of Cardiology
|
October 9, 2015
Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures
Philip L Mar, Dmitry Familtsev, Michael D Ezekowitz, et al.
Circulation
|
September 27, 2006
Images in cardiovascular medicine. The case of a disappearing left atrial appendage thrombus: direct visualization of left atrial thrombus migration, captured by echocardiography, in a patient with atrial fibrillation, resulting in a stroke
Amit Parekh, Radhika Jaladi, Sushant Sharma, et al.
The New England Journal of Medicine
|
November 5, 2010
Newly identified events in the RE-LY trial
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 16, 2002
Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering
Roberta Baetta, Marina Camera, Carmen Comparato, et al.
American Heart Journal
|
November 14, 2017
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
Gregory Y H Lip, Naab Al-Saady, Michael D Ezekowitz, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 8, 2015
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score
Masatsugu Hori, Taku Fukaya, Eva Kleine, et al.
Page
of 19